Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Myristoleic Acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Fatty acids of similar chain length share micellar packaging, enterocyte uptake and the elongase and desaturase machinery downstream. Where one is abundant it occupies enzyme capacity the other would otherwise use. This is a general fatty acid principle and does not imply a problem at ordinary dietary intakes.
Chain length dictates the absorption route: below about 12 carbons fats go portal, above it they go lymphatic via chylomicrons. Myristoleic acid at 14 carbons is firmly in the chylomicron group. Mixing the two in one formula means two different transport fates from the same capsule.
Any oil containing a double bond will oxidise on exposure to oxygen, heat and light, and tocopherol is the standard protection both in the bottle and in the membrane. A single double bond makes myristoleic acid far less peroxidation-prone than a polyunsaturate, so the requirement is lower than for fish oil. The pairing is formulation convention with sound chemistry behind it.
Tocopherol is consumed each time it quenches a lipid radical unless something reduces it back. Ascorbate does that at the aqueous interface of the membrane. This is settled redox biochemistry and applies to any unsaturated lipid, not specifically to this one.
Cholecalciferol absorption is poor without a fat load to trigger bile release and form mixed micelles. A long-chain fatty acid is an adequate vehicle for that purpose. The relationship is generic to dietary fat and confers nothing special on this particular fatty acid.
Membrane phospholipid composition reflects the relative supply of available fatty acids, since the acyltransferases handling remodelling are not exclusive to one species. A large intake of one shifts the ratio incorporated. The direction and magnitude of any shift from a 14-carbon monounsaturate has not been quantified in people.
Lipase acts at the oil-water interface, so anything that increases that interface increases hydrolysis rate. Lecithin is the standard emulsifier used for this in oil-filled softgels. The effect is on dispersion, not on the fatty acid itself.
A fatty acid delivered as a triglyceride is not absorbable until lipase cleaves it. Where pancreatic output is reduced, supplemental lipase addresses that step. This is a general lipid digestion requirement and is not specific to any one fatty acid.
Micelle formation is the rate-limiting step for long-chain fatty acid uptake, and bile salts are what make micelles form. This matters for anyone with reduced bile flow or after gallbladder removal. It is a general lipid principle applied to a 14-carbon fatty acid.
The carnitine shuttle is the gate for long-chain fatty acid entry into mitochondria, and chain lengths of roughly 14 and above go through it. Carnitine is normally made endogenously in sufficient quantity, so this describes the pathway rather than establishing a supplementation need.
Every turn of the beta-oxidation spiral passes electrons through an FAD-dependent dehydrogenase. Riboflavin deficiency impairs fatty acid oxidation for that reason, which is documented biochemistry. At normal riboflavin intakes this is not a limiting step.
Carotenoid absorption depends on co-ingested fat for micelle formation, so an oil vehicle raises uptake substantially compared with a dry powder. The relationship runs in the direction of the oil helping the carotenoid. Any protective effect back on the oil is plausible from astaxanthin's membrane position but has not been quantified for this fatty acid.
Nothing specific on file for Myristoleic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Myristoleic Acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.